These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35340525)

  • 1. Use of Systemic Anticoagulation in COVID-19: Delving Beyond Theoretical Hypothesis.
    Millet C; Narvaneni S; Shafeek F; Roman S; Mechineni A; Manickam R
    Cureus; 2022 Feb; 14(2):e22061. PubMed ID: 35340525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Standard Versus Intermediate Prophylaxis Dose for Venous Thromboembolism Prophylaxis in Patients Hospitalized With COVID-19 Infection.
    Chakabva MS; Polina S; Brauner M; McGuire M; Brown Z; Akthar T; Todt M; Polina A; Nova FF
    Hosp Pharm; 2024 Feb; 59(1):94-101. PubMed ID: 38223865
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
    ; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
    JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between standard Vs. Escalated dose venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19: A two centers, observational study.
    Aljuhani O; Al Sulaiman K; Hafiz A; Eljaaly K; Alharbi A; Algarni R; Al Homaid S; Kahtani K; Alsulaiman T; Vishwakarma R; Al Ghamdi G; Alalawi M; Korayem GB
    Saudi Pharm J; 2022 Apr; 30(4):398-406. PubMed ID: 35136364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Venous Thromboembolism and Effect of Anticoagulant Dosing in Hospitalized COVID-19 Patients.
    Kumar G; Patel D; Odeh T; Rojas E; Sakhuja A; Meersman M; Dalton D; Nanchal R; Guddati AK
    J Hematol; 2021 Aug; 10(4):162-170. PubMed ID: 34527112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Coronavirus Infection (COVID-19) Related Thrombotic and Bleeding Complications in Critically Ill Patients: Experience from an Academic Medical Center.
    Jayakrishnan T; Haag A; Mealy S; Minich C; Attah A; Turk M; Alrifai N; Alhuneafat L; Khoury F; Nasrullah A; Wedgeworth P; Mosley M; Vashistha K; Bakalov V; Chaturvedi A; Sangli S
    J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased incidence of venous thromboembolism after spine surgery with early multimodal prophylaxis: Clinical article.
    Cox JB; Weaver KJ; Neal DW; Jacob RP; Hoh DJ
    J Neurosurg Spine; 2014 Oct; 21(4):677-84. PubMed ID: 25105337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Infection in Critically Ill Patients Carries a High Risk of Venous Thrombo-embolism.
    Bellmunt-Montoya S; Riera C; Gil D; Rodríguez M; García-Reyes M; Martínez-Carnovale L; Marrero C; Gil M; Ruiz-Rodríguez JC; Ferrer R; de Nadal M; Monreal M; Llagostera S
    Eur J Vasc Endovasc Surg; 2021 Apr; 61(4):628-634. PubMed ID: 33583710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empiric use of anticoagulation in hospitalized patients with COVID-19: a propensity score-matched study of risks and benefits.
    Yu B; Gutierrez VP; Carlos A; Hoge G; Pillai A; Kelly JD; Menon V
    Biomark Res; 2021 May; 9(1):29. PubMed ID: 33933168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT Study.
    Akinosoglou K; Savopoulos C; Pouliakis A; Triantafyllidis C; Markatis E; Golemi F; Liontos A; Vadala C; Papanikolaou IC; Dimakopoulou V; Xarras P; Varela K; Kaiafa G; Mitsianis A; Chatzistamati A; Randou E; Savvanis S; Pavlaki M; Efraimidis G; Samaras V; Papazoglou D; Konstantinidou A; Panagopoulos P; Milionis H; On Behalf Of The Interact Study Group
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation strategy and safety in critically ill COVID-19 patients: a French retrospective multicentre study.
    Lamouche-Wilquin P; Perrin L; Pere M; Raymond M; Asfar P; Darreau C; Reizine F; Colin G; Delbove A; Auchabie J; Hourmant B; Frérou A; Combe B; Morin J; Kergoat P; Lorber J; Egreteau PY; Souchard J; Canet E; Lascarrou JB
    Thromb J; 2023 Apr; 21(1):42. PubMed ID: 37072788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No Difference Between Low- and Regular-dose Aspirin for Venous Thromboembolism Prophylaxis After THA.
    Faour M; Piuzzi NS; Brigati DP; Klika AK; Mont MA; Barsoum WK; Higuera CA
    Clin Orthop Relat Res; 2019 Feb; 477(2):396-402. PubMed ID: 30624322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute high-risk pulmonary embolism requiring thrombolytic therapy in a COVID-19 pneumonia patient despite intermediate dosing deep vein thromboprophylaxis.
    Salam S; Mallat J; Elkambergy H
    Respir Med Case Rep; 2020; 31():101263. PubMed ID: 33083223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous Thrombo-Embolism in Hospitalized SARS-CoV-2 Patients Treated with Three Different Anticoagulation Protocols: Prospective Observational Study.
    Longhitano Y; Racca F; Zanza C; Muncinelli M; Guagliano A; Peretti E; Minerba AC; Mari M; Boverio R; Salio M; Chichino G; Franceschi F; Piccioni A; Abenavoli L; Salvini M; Artico M
    Biology (Basel); 2020 Sep; 9(10):. PubMed ID: 32987902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Anticoagulation May Be Associated with Reduced 14-day Mortality in Mechanically Ventilated Patients with COVID-19.
    Jenkins R; Sheth S; Nestor B; Mazer A
    Innov Pharm; 2021; 12(3):. PubMed ID: 35601571
    [No Abstract]   [Full Text] [Related]  

  • 16. Intermediate- vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study.
    Smadja DM; Bonnet G; Gendron N; Weizman O; Khider L; Trimaille A; Mirault T; Fauvel C; Diehl JL; Mika D; Philippe A; Pezel T; Goudot G; Sutter W; Planquette B; Waldmann V; Sanchez O; Cohen A; Chocron R
    Front Med (Lausanne); 2021; 8():747527. PubMed ID: 34722585
    [No Abstract]   [Full Text] [Related]  

  • 17. Timing of Prophylactic Anticoagulation and Its Effect on Thromboembolic Events After Surgery for Metastatic Tumors of the Spine.
    De la Garza Ramos R; Longo M; Gelfand Y; Echt M; Kinon MD; Yassari R
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E650-E655. PubMed ID: 30475345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of thrombolysis using tissue plasminogen activator in lower extremity deep venous thrombosis with concomitant femoral-popliteal venous segment involvement.
    Lin M; Hsieh JCF; Hanif M; McDaniel A; Chew DK
    J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):613-620. PubMed ID: 28818211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis and Bleeding After Implementation of an Intermediate-Dose Prophylactic Anticoagulation Protocol in ICU Patients With COVID-19: A Multicenter Screening Study.
    Al-Abani K; Kilhamn N; Maret E; Mårtensson J
    J Intensive Care Med; 2022 Apr; 37(4):480-490. PubMed ID: 34821162
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.